Clinical Trials Directory

Trials / Completed

CompletedNCT05812300

Local Injection of Periodontal Pocket Method for the Treatment of Gingivitis

The Clinical Study of Injection of Freshly Prepared HA35 for Treatment Gingivitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Dove Medical Press Ltd · Network
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Preliminary clinical studies have confirmed that injection of freshly prepared HA35 can reduce symptoms and signs of gingivitis or periodontitis. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.

Detailed description

The previous studies showed that toothpastes containing the cosmetic grade raw material of the 35 kDa low molecular hyaluronan fragment HA35 significantly reduced symptoms and signs of gingivitis or periodontitis. In this study, patients with mild to moderate periodontitis suffering from symptoms and signs, including discomfort and swelling and bleeding of periodontal tissue, were treated by intrapocket injection of freshly manufactured hyaluronan fragment HA35. This study is an repeat clinical study comparing pre- and posttreatment effects similar to others.

Conditions

Interventions

TypeNameDescription
DRUGFreshly manufactured 35 kDa hyaluronan fragmentThe study was an open-label clinical trial. A pre- and posttreatment controlled study approach was used, whereby the investigator injected 35 kDa hyaluronan fragment HA35 into the periodontal pocket in a single dose of 100 mg. The distribution of the injection amount was determined by the location of gingival inflammation.

Timeline

Start date
2023-06-01
Primary completion
2024-01-01
Completion
2024-02-20
First posted
2023-04-13
Last updated
2024-04-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05812300. Inclusion in this directory is not an endorsement.